Introduction

44
This project is for extended follow-up of participants in the Hyperlink study.
46
The study will observe participants through 54 months (4.5 years) from baseline to examine the 47 long-term effects of the Hyperlink intervention on blood pressure and cardiovascular events. 48
We will also investigate cost effectiveness and dissemination of the intervention into regular 49 health care practice. 50
Project Summary
51
Hypertension affects nearly 70 million Americans, and is effectively controlled in less than half.
52
Because uncontrolled hypertension is a leading cause of stroke, congestive heart failure, renal 53 disease, and myocardial infarction, development of cost-effective and scalable hypertension 54 control strategies has been identified as an urgent national priority. The NHLBI-funded 55 randomized HyperLink trial (Home Blood Pressure Telemonitoring and Case Management to 56
Control Hypertension) has developed and implemented a very effective yet simple two-step 57 non-office-based blood pressure (BP) control strategy: (a) patients measured BP at home using 58 telemonitors that stored and electronically transmitted BP data to a pharmacist via a telephone 59 modem, (b) In periodic telephone visits, pharmacists advised patients on medication adherence 60 and lifestyle, and adjusted antihypertensive therapy under a collaborative practice agreement 61 with primary care physicians. This simple strategy has now been rigorously evaluated in a 62 randomized trial in which a high proportion of patients achieved and maintained BP control at 63 6, 12, and 18 months following enrollment (71%-72%) compared to usual care (45%-57%, P<.01 64 at all time points). It achieved systolic BP 11 mm Hg lower at 6 months (P<0.0001), 10 mm Hg 65 lower at 12 months (P<0.0001), and 7 mm Hg lower at 18 months (P=0.004) in the intervention 66 group compared to the usual care group. 67 68
The purpose of this proposal is to extend follow-up of the 450 patients enrolled in the 69
HyperLink intervention and usual care groups to achieve three specific aims: (a) provide new 70 data on the long-term durability (b) assess the cost-effectiveness of the Hyperlink intervention, 71 and (c) use mixed methods to identify critical factors for delivering the intervention successfully 72 and translating it into practice. All patients will be invited to attend two research clinic visits to 73 measure BP 5 years following enrollment. Extended data will include assessments of BMI, 74
antihypertensive treatment and adherence, use of home BP monitoring, satisfaction with 75 medical care, and surveillance for clinical cardiovascular events. Data collected at visits will be 76 supplemented with interim BP measures extracted from electronic medical records. Long-term 77 health impact and cost-effectiveness will be quantified using directly observed measures and 78 state-of-the-art microsimulation prediction modeling of cardiovascular events and treatment 79 costs. Focus groups and semi-structured interviews with study subjects, pharmacists, and 80 health system stakeholders will provide additional perspectives on 1) optimizing successful 81 delivery of the intervention, and 2) on strategies and barriers for translation into clinical 82 practice. These results will fill critically important knowledge gaps and provide practical 83 information about the costs and benefits of implementing a this scalable and effective new care 84 model that holds great promise for improving outcomes for millions of Americans with 85 uncontrolled hypertension. 86
Study Procedures
87
Study Timeline
88
This timeline is a revised version of our originally proposed study timeline. A more task-specific 89 timeline is kept in the project folder in the "Project Management/Project timeline" subfolder. 90 91 
Identifying excluded participants 112
Prior to beginning recruitment, the study coordinators, project manager, and programmer will 113 review records to identify participants who shall be excluded from the study for reasons of 114 death, previously requesting to not be contacted by the study, and new dementia or mental 115 illness.
117
Death: The programmer will review all medical record and claims data for evidence of 118 death among the 450 participants. Patients who are deceased will be marked as 119 excluded in the database for reason of death. Death records will be collected from the 120 state and from medical records where possible (see below section on death records). 121 122
Previous study drop-outs: Participants will remain eligible and be contacted even if they 123
were "lost to follow-up" (i.e., missed several visits or stopped responding to our 124 attempts to reach them). Participants who dropped out for other reasons or specifically 125 told us they do not want to be contacted by our study will be excluded from 126 recruitment. The project manager and study coordinators will identify those participants 127 using our old drop-out notes from the original Hyperlink study. 
Levels of follow-up 160
Participants will be invited to attend the two specified clinic visits at the Riverside Research 161
Clinic. However, because some participants in the original study expressed distress at traveling 162 to Riverside (and thus did not attend study visits), we will offer other options for participating 163 (see Table 2 
Follow-up Recruitment Letter 204
Once patient is determined difficult to reach or not answering phone, you can send a second 205 follow-up letter stating that we have been trying to reach the patient for a study opportunity.
206
Please log the second letter into the Recruitment form communication log.
208
The follow-up recruitment letter is found under Appendix C. 209
Database management 210
All recruitment letters and phone calls and their outcomes will be logged in the RedCap 211 database under each participant's Recruitment Form. 212
Unresponsive patients 213
When the coordinator cannot reach a participant using the initial means of recruitment letter 214 and follow-up phone calls, we must make other attempts to reach the patient. These options 215 should be exhausted before declaring a participant "lost." 216 217
Electronic Medical Record: The coordinator will look in the participant's electronic 218 medical record for any alternative contact information, including phone numbers or 219 addresses, and/or any indication of backup or family contact information. If any 220 alternative information is found, the coordinator will record with notes in the 221 participant's RedCap recruitment form. The coordinator can then re-send the 222 recruitment letter or begin calling the participant as appropriate. In the event of using 223 backup or family contacts, the coordinator should NOT identify the research study as 224 the reason for trying to get ahold of the patient. The coordinator can identify they are 225 calling from HealthPartners, but nothing more specific.
227
Follow-up letter: After the above means are exhausted, we will send the recruitment 228 letter a second time incase it was originally lost. We will include a cover letter explaining 229
we have made several attempts to reach the participant but have not been able to get 230 ahold of them. (Send both the original recruitment letter and follow-up letter together 231 for this mailing -Appendices A and C). 232 233
Checking death records: Every 6 months, the HPIER programmer will look in the EMR 234 among participants for indication of death. However, upon continued inability to reach 235 participants the coordinator may also look for indication of death in the EMR and 236 through various other means (i.e., searching online databases). See death records 237 section of MOP for record keeping instructions. 238
Reports generated by RedCap database 239
The RedCap project offers customizable reports to help us manage patient schedules and 240 progress through the study. We can add reports as desired. Currently, the reports available are:
Introduction letter: To send first letter to all patients. Visit 2 (54 months+2 weeks) 546 
547
The purpose of the 2-week follow up visit (V2) is to take a second set of blood pressure 548 measurements to improve accuracy of the long-term blood pressure outcome. 
Cardiovascular Event, Death Records
571
We will collect medical records of all reported events that are collected from the V1 questions. 572
Most of the questions have very clear yes or no answers, but occasionally there will be "gray 573 area" events that are unclear as to whether an event of interest actually occurred. 574 575
Please print or request records for all events of interest and re-route to Anna's office at 576
Ceridian. For hospital stays, we need discharge summaries if possible. For ED visits we need an 577 ED summary. For anything involving an office visit, we'd like to see the office visit where the 578 diagnosis was made or event described. If you cannot locate these, please send any 579 documentation you can find that references the incident and we will track down any necessary 580 supporting docs. 581 582
As for deaths, we will collect death information for all patients that we learn have died during 583 the study period. Please inform Anna when a death has occurred. If the death occurred during 584 an attempt for recruitment, please mark "excluded" in the recruitment database with the 585 reason being deceased. Please also note all details that you know of surrounding the death so 586 that we can track down the necessary documentation. For patients who you learn have 587 deceased at some time later, please let Anna know. We will be recording all deaths. For death 588 adjudication, 589 590
All events and death reports will be reviewed by Karen or Joann to determine the final event 591
category. Anna will coordinate this and keep a spreadsheet of all reports and final 592 adjudications. 593
Focus Group Participation
595
Identification and Recruitment of FG participants 596
We will hold a series of patient focus groups to better understand the reasons some patients 597 were more successful in lowering their blood pressure through this intervention than others. 598 Focus groups will be stratified by: treatment group, blood pressure patterns over time. 599 600
We will select focus group participants among those completing a V1 visit. Among those 601 patients, we will sort by treatment group X blood pressure outcomes at 6, 12, 18, and 54 602 months. The following strata are identified: 603 604
Telemonitoring Intervention Usual Care 1a. Always in control 1. Always in control 1b. Always in control, not long term (relapsed 54m) 2. Never in control 2. Never in control 3. Achieved control and maintained, late start 3. Achieve control at 12 months 4. Relapsers (mixed) 4. Relapsers (mixed) 605
Patients falling into these categories will be invited to join a focus group by mail, followed by a 606 phone call from the project manager. See Appendix E for focus group recruitment material. 607 608
Groups will be scheduled as they fill with at least 4 participants. Ideally groups will have 5-7 609 participants each. 610 611 612
Focus Group guide 613
See Appendix F for final focus group facilitation guides. 614 615
Conducting the Focus groups 616
Procedures for conducting the focus groups are as follows:
The purpose of these discussion groups is to learn why some participants had better results 619
with Hyperlink than others in lowering their BP. We have selected groups of participants based 620 on how their blood pressure changed over time during the intervention and long after. 621 622
Facilitator: Anna 623
Co-facilitator/assistant: Ann Tucker, Julie Anderson, Sarah Basile, Amy LaFrance 624 625
Preparations ahead of group (week before/day before) 626  Gift cards 627 o $50 Target gift cards will be purchased and kept in Anna's locked desk at 628
Riverside. All the serial #s will be tracked in this spreadsheet: (make 629 spreadsheet). Prior to group, cards will be recorded with date and participant's 630 studyID they are given to in that sheet. 
Unanticipated Problems or Adverse Events
765
Because this is an observational study without intervention, we are not systematically 766 monitoring patients for medical events potentially related to hypertension treatment. We will, 767 however, record all self-reported cardiovascular events as described above which will be 768 assessed for potential relationship to hypertension treatment. Self-reported data will be 769 supplemented with claims and medical records at the conclusion of the study. 770 771
Any unanticipated problems related to patient safety, privacy, or other concerns will be 772 reported to the IRB if applicable. 
782
You might recall that the purpose of the Hyperlink study was to test a program for blood pressure 783 management that involved using a home blood pressure telemonitor and receiving support from a 784 pharmacist over 12 months. About half the participants received that program, and the other half 785 worked with their doctors like they normally would. Everyone in the study was invited to an enrollment 786 visit at the HealthPartners Riverside Research Clinic and then to follow-up visits at 6, 12, and 18 months 787 after enrollment. We are happy to report that we have now completed all those visits, and we are 788 thankful for your participation.
790
The Hyperlink study was quite successful in gathering new information about blood pressure 791 management. Our short-term results suggest the home monitoring and pharmacist support combination 792 was effective in helping people lower their blood pressure. We will be sharing the official results with 793 you soon via newsletter, so please watch for that information.
795
It is important for us to know if the short-term results translate to long-term effects, so we have applied 
801
Everyone is invited to come back for one visit at 54 months (4.5 years) after enrollment, and a second 
806
The first visit would involve taking your blood pressure and filling out questionnaires similar to what you 807 did in the past. The second visit would be only a simple blood pressure check. There will be no labs with 808 these visits, and you will receive a $40 gift card for the 54 month visit and a $20 gift card for the second 809 visit (BP check). Participation in this study does not involve any additional home monitoring or 810 pharmacist services -you will just continue taking care of your blood pressure like you normally would.
811
Finally, you may also be invited to provide feedback about your experience in Hyperlink through focus 812 groups or interviews. You will be notified separately if selected for that part of the study. Because these 813 visits were not part of our original plan, we will have a new consent form for you to review and sign that 814 will explain other details of the new study elements. 
816
